{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:44:24Z","timestamp":1760575464130,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443296123"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.mcb.2025.02.015","type":"book-chapter","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:25:47Z","timestamp":1742228747000},"page":"133-149","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune arthritis: Transgenic mouse models and methods"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.mcb.2025.02.015_bib1","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.4049\/jimmunol.164.11.5788","article-title":"Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR","volume":"164","author":"Basu","year":"2000","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-60761-058-8_11","article-title":"Collagen-induced arthritis in mice","volume":"602","author":"Bevaart","year":"2010","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nature Protocols"},{"key":"10.1016\/bs.mcb.2025.02.015_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41584-018-0074-9","article-title":"Rheumatic immune-related adverse events from cancer immunotherapy","volume":"14","author":"Calabrese","year":"2018","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib5","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R","article-title":"Collagen-induced arthritis in C57BL\/6 (H-2b) mice: New insights into an important disease model of rheumatoid arthritis","volume":"30","author":"Campbell","year":"2000","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib6","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/acr.23177","article-title":"Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: A systematic review of the literature","volume":"69","author":"Cappelli","year":"2017","journal-title":"Arthritis Care & Research: an Official Journal of the American College of Rheumatology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/imt-2016-0117","article-title":"Inflammatory arthritis due to immune checkpoint inhibitors: Challenges in diagnosis and treatment","volume":"9","author":"Cappelli","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/bs.mcb.2025.02.015_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000321","article-title":"Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities","volume":"2","author":"Cappelli","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/bs.mcb.2025.02.015_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/imr.12832","article-title":"Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis","volume":"294","author":"Cappelli","year":"2020","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.mcb.2025.02.015_bib10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2353\/ajpath.2008.071008","article-title":"Sex differences in autoimmune disease from a pathological perspective","volume":"173","author":"Fairweather","year":"2008","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.888377","article-title":"Clinical patterns and follow-up of inflammatory arthritis and other immune-related adverse events induced by checkpoint inhibitors. A multicenter study","volume":"9","author":"Gomez-Puerta","year":"2022","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/bs.mcb.2025.02.015_bib12","first-page":"305","article-title":"Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis","volume":"65","author":"Holmdahl","year":"1988","journal-title":"Immunology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib13","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/art.21192","article-title":"Dipeptidyl peptidase I regulates the development of collagen-induced arthritis","volume":"52","author":"Hu","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/bs.mcb.2025.02.015_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3899\/jrheum.190084","article-title":"Immune-related adverse events associated with cancer immunotherapy: A review for the practicing rheumatologist","volume":"47","author":"Jamal","year":"2020","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ni0502-411b","article-title":"Few human autoimmune sera detect GPI","volume":"3","author":"Kassahn","year":"2002","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","article-title":"From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins","volume":"10","author":"Korganow","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/bs.mcb.2025.02.015_bib17","first-page":"147","article-title":"A new mouse model of rheumatoid arthritis: Organ-specific disease provoked by systemic autoimmunity","volume":"37","author":"Kouskoff","year":"1997","journal-title":"Ryumachi. [Rheumatism]"},{"key":"10.1016\/bs.mcb.2025.02.015_bib18","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2353\/ajpath.2010.100195","article-title":"Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K\/BxN mouse","volume":"177","author":"LaBranche","year":"2010","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib19","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1084\/jem.20060701","article-title":"Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help","volume":"203","author":"Mandik-Nayak","year":"2006","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.mcb.2025.02.015_bib20","doi-asserted-by":"crossref","first-page":"14368","DOI":"10.1073\/pnas.182549099","article-title":"Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node","volume":"99","author":"Mandik-Nayak","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.015_bib21","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1126\/science.286.5445.1732","article-title":"Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme","volume":"286","author":"Matsumoto","year":"1999","journal-title":"Science"},{"key":"10.1016\/bs.mcb.2025.02.015_bib22","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/S2665-9913(23)00064-4","article-title":"Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: A retrospective, comparative, cohort study","volume":"5","author":"McCarter","year":"2023","journal-title":"The Lancet. Rheumatology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib23","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.4049\/jimmunol.1600141","article-title":"IDO2 modulates T cell-dependent autoimmune responses through a B cell-intrinsic mechanism","volume":"196","author":"Merlo","year":"2016","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib24","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.4049\/jimmunol.1303012","article-title":"IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis","volume":"192","author":"Merlo","year":"2014","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","article-title":"Immune-related adverse events with immune checkpoint blockade: A comprehensive review","volume":"54","author":"Michot","year":"2016","journal-title":"European Journal of Cancer"},{"key":"10.1016\/bs.mcb.2025.02.015_bib26","first-page":"15 22 1","article-title":"The K\/BxN arthritis model","volume":"Chapter 15","author":"Monach","year":"2008","journal-title":"Current Protocols in Immunology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-59745-402-5_20","article-title":"The K\/BxN mouse model of inflammatory arthritis: Theory and practice","volume":"136","author":"Monach","year":"2007","journal-title":"Methods in Molecular Medicine"},{"key":"10.1016\/bs.mcb.2025.02.015_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1634\/theoncologist.2016-0390","article-title":"Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade","volume":"22","author":"Naidoo","year":"2017","journal-title":"The Oncologist"},{"key":"10.1016\/bs.mcb.2025.02.015_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/B:JOCI.0000040919.16739.44","article-title":"Resistance to development of collagen-induced arthritis in C57BL\/6 mice is due to a defect in secondary, but not in primary, immune response","volume":"24","author":"Pan","year":"2004","journal-title":"Journal of Clinical Immunology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ni0502-411a","article-title":"Autoantibodies to GPI and creatine kinase in RA","volume":"3","author":"Schubert","year":"2002","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.mcb.2025.02.015_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.rdc.2024.02.002","article-title":"Immune checkpoint inhibitor-induced inflammatory arthritis: Current approaches to management","volume":"50","author":"Singh","year":"2024","journal-title":"Rheumatic Diseases Clinics of North America"},{"key":"10.1016\/bs.mcb.2025.02.015_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152460","article-title":"Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis","volume":"67","author":"Wallwork","year":"2024","journal-title":"Seminars in Arthritis and Rheumatism"}],"container-title":["Methods in Cell Biology","Immuno-Oncology and Immunotherapy - Part E"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:49:18Z","timestamp":1760532558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X25000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443296123"],"references-count":32,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2025.02.015","relation":{},"ISSN":["0091-679X"],"issn-type":[{"type":"print","value":"0091-679X"}],"subject":[],"published":{"date-parts":[[2025]]}}}